Well Referenced

Tag: goserelin

Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators: A Phase 2 Randomized Clinical Trial

This 2021 phase 2 randomized clinical trial (MIRACLE study) assessed the benefit of adding everolimus to letrozole in premenopausal women with hormone receptor-positive, ERBB2-negative advanced breast cancer who had progressed on selective estrogen receptor modulators (SERMs). A total of 199 patients were randomized to receive either everolimus (10 mg/day) with

Read More »
June 26, 2025 No Comments

First-line treatment of metastatic prostate cancer. Androgen suppression for symptomatic disease

A review published in Prescrire International (2013) evaluated first-line treatments for metastatic prostate cancer, focusing on androgen suppression therapies like orchiectomy and gonadorelin agonists, which provide significant pain relief for about 80% of patients with bone metastases. However, the effect of these therapies on overall survival remains uncertain. Nonsteroidal antiandrogen

Read More »
June 26, 2025 No Comments